Stocksigma LogoStocksigma Logo

Ganga Pharmaceuticals Reports H1 FY27 Results with Profit Decline

Ganga Pharmaceuticals posted revenue from operations of ₹141.63 lakh for the half-year ended 30th Sep'26, rising 3.6% YoY from ₹136.65 lakh in the

Ganga Pharmaceuticals Reports H1 FY27 Results with Profit Decline

Ganga Pharmaceuticals Ltd · Outcome · 02 Nov 2026, 10:10 pm

Ganga Pharmaceuticals Reports H1 FY27 Results with Profit Decline Ganga Pharmaceuticals posted revenue from operations of ₹141.63 lakh for the half-year ended 30th Sep'26, rising 3.6% YoY from ₹136.65 lakh in the corresponding period ended 30th Sep'25. Total income reached ₹155.27 lakh versus ₹146.91 lakh YoY. However, net profit dropped 66.2% YoY to ₹1.86 lakh compared to ₹5.50 lakh, pressured by higher raw material costs of ₹80.42 lakh and employee expenses of ₹32.72 lakh. Half-year basic and diluted EPS declined to ₹0.03 from ₹0.04 YoY.

Original exchange filing (PDF)

More announcements from Ganga Pharmaceuticals Ltd

All Ganga Pharmaceuticals Ltd announcements